Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2949576 | 1.00 | MEN1 (0.41) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL195733 | 0.93 | — | — | |
| SCHEMBL7422695 | 0.91 | TSHR (0.41) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL7526964 | 0.90 | ALDH1A1 (0.39) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2532522 | 0.90 | ALDH1A1 (0.39) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL8782077 | 0.90 | ALDH1A1 (0.38) | MEN1KMT2AHTTTSHRGAA | |
| SCHEMBL344909 | 0.90 | ALDH1A1 (0.39) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2528683 | 0.90 | ALDH1A1 (0.39) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1002493 | 0.88 | ALDH1A1 (0.38) | MEN1KMT2ATHRBHTTMAPT | |
| Succinic Acid SCHEMBL2963047 | 0.87 | GAA (0.42) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7766978-B2 | Acidic hair dyeing method | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2010-08-03 | — | — | US | claimed |
| US-20090100609-A1 | ACIDIC HAIR DYE COMPOSITION | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2009-04-23 | — | — | US | claimed |
| EP-2392314-B1 | OILY HAIR COSMETIC | KOKYU ALCOHOL KOGYO CO LTD (JP) | 2019-08-14 | — | — | EP | disclosed |
| US-9617438-B2 | Oily inkjet ink | RISO KAGAKU CORPORATION (JP) | 2017-04-11 | — | — | US | disclosed |
| US-8562957-B2 | Oily hair cosmetics | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20110315049-A1 | OILY INKJET INK | RISO KAGAKU CORPORATION (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20100203003-A1 | Oily Hair Cosmetics | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
| US-7766978-B2 | Acidic hair dyeing method | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090100609-A1 | ACIDIC HAIR DYE COMPOSITION | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090100609-A1 | ACIDIC HAIR DYE COMPOSITION | H1-0, MRM1, H1-4 | MEN1 157/4885KMT2A 2163/4885THRB 3372/4885 |
| US-20100203003-A1 | Oily Hair Cosmetics | H1-0, H1-2, H1-3 | MEN1 85/4885KMT2A 842/4885THRB 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.